{"disease":{"id":"plaque-psoriasis-vulgaris","name":"plaque psoriasis vulgaris"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04533737","title":"Efficacy and Safety of Brodalumab Compared With Guselkumab in the Treatment of Plaque Psoriasis After Inadequate Response to Ustekinumab","phase":"PHASE4","overall_status":"TERMINATED","enrollment_count":113,"lead_sponsor_name":"LEO Pharma","has_results":true},{"nct_id":"NCT02976831","title":"Study to Assess the Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of AZD0284 in Healthy Subjects","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":83,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT07428915","title":"Evaluating Legit.Health Plus Support for Improving Diagnosis of Generalized Pustular Psoriasis and Other Skin Conditions Among Primary Care Physicians and Dermatologists","phase":"","overall_status":"COMPLETED","enrollment_count":15,"lead_sponsor_name":"AI Labs Group S.L","has_results":false},{"nct_id":"NCT05442190","title":"Topical SGX302 for Mild-to-Moderate Psoriasis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":15,"lead_sponsor_name":"Soligenix","has_results":false},{"nct_id":"NCT03310320","title":"Study to Determine if AZD0284 is Effective and Safe in Treating Plaque Psoriasis","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":9,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT03029741","title":"Bioavailability of AZD0284 and IV Microtracer Study","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":6,"lead_sponsor_name":"AstraZeneca","has_results":false}],"total":6},"guidelines":[],"source":"Drug Landscape verified database"}